Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with bevacizumab for treatment of brain metastases in metastatic melanoma or non-small…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors [Phase 1]
Phase 1, first-in-human dose-finding and expansion study of XmAb808 in combination with pembrolizumab in advanced solid tumors; the trial ha…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments
This clinical trial update reports on real-world treatment patterns and outcomes in Chinese patients with advanced non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer [Phase 3]
A Phase 3 trial evaluating Taxoprexin with carboplatin for advanced non-small cell lung cancer has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects [Phase 1, Phase 2]
Phase 1/2 clinical trial assessing SBRT with immunotherapy for early-stage non-small cell lung cancer, focusing on tolerability and lung eff…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Prognostic Value of Sarcopenia and Nutritional Status in Early-stage Non-small Cell Lung Cancer
A completed study investigated whether sarcopenia and nutritional status can prognosticate outcomes in patients with early-stage non-small c…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Subcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung Cancer
A completed clinical trial comparing subcostal single-port robotic lobectomy versus intercostal multi-port robotic lobectomy for non-small c…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: MGC018 With or Without MGA012 in Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports results from the combination of MGC018 with or without MGA012 (pembrolizumab) in advanced solid tumors. T…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Alaunos Therapeutics reports long-term follow-up data from subjects treated with autologous T cells engineered with a Sleeping Beauty system…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma [Phase 1]
Phase 1 trial evaluating Camu-Camu prebiotic with immune checkpoint inhibition in patients with advanced non-small cell lung cancer and mela…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China
This clinical trial update reports a completed real-world study in China examining adjuvant therapy for early-stage non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study of GT103 in combination with pembrolizumab for refractory, metastatic non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Efficacy and Safety Analysis of First-Line ABCP Therapy in Advanced SMARCA4-Mutated NSCLC
The update outlines an ongoing trial evaluating first-line ABCP therapy for advanced SMARCA4-mutated non-small cell lung cancer, with the st…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Follow-up of Patients With Curative-intent Surgical Resection for NSCLC [NA]
A completed clinical trial evaluating outcomes after curative-intent surgical resection for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC [Phase 2]
A Phase 2 trial of immunotherapy combined with non-ablative radiation in previously untreated stage IV non-small cell lung cancer was termin…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77) [Phase 3]
Phase 3 trial comparing subcutaneous pembrolizumab coformulated with hyaluronidase alfa (MK-3475A) vs intravenous pembrolizumab in adults wi…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC)
The Boehringer Ingelheim-sponsored trial evaluating Vargatef as second-line therapy for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating the combination of concurrent chemoradiotherapy with surufatinib and tislelizumab for locally advance…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery [Phase 3]
This document reports the completion of a Phase 3 study evaluating the combination of nivolumab and ipilimumab in untreated stage 3 non-smal…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: A Phase I Study of XZP-3621 in Chinese Patients With ALK or ROS1 Rearrangement Non-small Cell Lung Cancer [Phase 1]
A Phase I trial evaluating XZP-3621 in Chinese patients with ALK- or ROS1-rearranged non-small cell lung cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer [Phase 3]
This document notes completion of a Phase 3 pharmaco-economic study evaluating a second-line treatment for advanced non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1 [Phase 1, Phase 2]
Phase 1/2 trial evaluating Trabedersen (OT-101) in combination with pembrolizumab for newly diagnosed advanced Non-small cell lung cancer wi…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Lorlatinib in ROS1+ NSCLC With Brain Metastasis [Phase 2]
Lorlatinib is being studied in a Phase 2 trial for ROS1-positive non-small cell lung cancer with brain metastases, which is currently not ye…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01) [Phase 3]
A Phase 3 trial comparing datopotamab deruxtecan (DS-1062a) to docetaxel in previously treated advanced or metastatic non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases [Phase 2]
Phase 2 study update of X-396 (ensartinib) in ALK-positive non-small cell lung cancer patients with brain metastases. The trial status is ac…